In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteins
- 1 February 1987
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 36 (4), 527-536
- https://doi.org/10.1016/0006-2952(87)90362-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavageBiochemical Pharmacology, 1985
- Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16, 213): Implications for mode of actionBiochemical Pharmacology, 1985
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Irreversible binding of etoposide (VP-16-213) to deoxyribonucleic acid and proteinsBiochemical Pharmacology, 1984
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- A rapid one-step purification of NADPH-cytochrome c (P-450) reductase from rat liver microsomesAnalytical Biochemistry, 1983
- VM 26 and VP 16–213: A comparative analysisCancer, 1977
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976
- Hydroperoxide dependent O-dealkylation reactions catalyzed by liver microsomal cytochrome P450Biochemical and Biophysical Research Communications, 1975
- Inhibition of hepatic oxidative xenobiotic metabolism by piperonyl butoxideBiochemical Pharmacology, 1972